| |
| |
| Drug Development & Formulation is Science.
Dose Design to Create Successful Treatments is Art. |
|
|
| Achieving development milestones is critical to progressing your molecule to the clinic, but this doesn’t always translate to successful medicines or better outcomes for patients and stakeholders.
OptiDose Design Solution is a new comprehensive drug design assessment consisting of a holistic review of the molecule, patient, and market considerations. |
|
|
| Led by Catalent’s highly experienced team of scientific advisors, this evaluation assesses key drug design considerations that can help create more successful treatments for all stakeholders. |
|
|
| |
| The Right Technologies to Address
Patient Needs, Reliably Supplied |
|
|
| Catalent’s comprehensive approach to drug development coupled with the broadest selection of advanced drug delivery technologies and manufacturing platforms available enables us to match stakeholder considerations with the right solutions. |
|
|
| Our broad range of advanced delivery technologies can address patient needs and challenges including, dose loading, taste masking, drug release, food effects and others. |
|
|
| |
| Executive Summary: PBPK Modelling for Optimizing Controlled Release Dosage Form Development |
|
|
| In this executive summary, we describe the benefits of controlled release, look at how to determine whether a drug is suitable for controlled release, review the application of PBPK modelling in controlled release formulation development and discuss how modified release products can be developed to deliver optimal patient outcomes. |
|
|
| |
| On-Demand Webinar: Exploring Pectin and the Advancement of Delayed Release Technology |
|
|
| Watch this on-demand webinar to hear experts provide an overview of why the properties and structure of pectin are well suited for site-specific delivery to the colon. In addition, experts will also provide insights into how softgel capsules, formed by the combination of both pectin and gelatin, are used in OptiGel® DR, a new delayed release delivery technology for pharmaceutical applications. Speakers will also discuss the impact of modifying a pectin shell encapsulating a controlled release fill matrix on drug release profile and kinetics. |
|
|
| |
| |
| Every molecule has a challenge. We have a solution.
|
|
|
| |
| or call +1 877 891 9609 to speak with one of our experts today!
|
|
|
